Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 134-142 , November 2005

Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus

  • Daniel A. Enquobahrie

      Affiliations

    • Center for Perinatal Studies, Swedish Medical Center, 747 Broadway, Suite 4 North, Seattle, WA 98122, USA
    • Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • Cardiovascular Health Research Unit, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 206 215 3054; fax: +1 206 386 3173.
    • ,
  • Michelle A. Williams

      Affiliations

    • Center for Perinatal Studies, Swedish Medical Center, 747 Broadway, Suite 4 North, Seattle, WA 98122, USA
    • Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • ,
  • Chunfang Qiu

      Affiliations

    • Center for Perinatal Studies, Swedish Medical Center, 747 Broadway, Suite 4 North, Seattle, WA 98122, USA
    • Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA, USA
    • ,
  • David A. Luthy

      Affiliations

    • Obstetrix Medical Group, Seattle, WA, USA

Received 8 July 2004 ,Revised 3 January 2005 ,Accepted 2 March 2005.

References 

  1. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus (The Organizing Committee). Diabetes Care. 1998;21:161–167
  2. Davis CL, Gutt M, Llabre MM, Marks JB, O'Sullivan MJ, Landel JE, et al. History of gestational diabetes, insulin resistance and coronary risk. J. Diabetes Complications. 1999;13:216–223
  3. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet. Med. 2004;21:103–113
  4. Dandrow RV, O'Sullivan JB. Obstetric hazards of gestational diabetes. Am. J. Obstet. Gynecol. 1966;1144–1147
  5. Di Cianni G, Miccoli R, Volpe L. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab. Res. Rev. 2003;19:259–270
  6. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J. Clin. Endocrinol. Metab. 2001;989–993
  7. Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496–1504
  8. Couch SC, Philipson EH, Bendel RB, Wijendran V, Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus: predictors of birth weight?. J. Reprod. Med. 1998;43:816–822
  9. Bartha JL, Comino-Delgado R, Martinez-Del-Fresno P, Fernandez-Barrios M, Bethencourt I, Moreno-Corral L. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J. Reprod. Med. 2000;45:185–189
  10. Clark CM, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance?. Diabetes Care. 1997;20:867–871
  11. Couch SC, Philipson EH, Bendel RB, Pujda LM, Milvae RA, Lammi-Keefe CJ. Elevated lipoprotein lipids and gestational hormones in women with diet-treated gestational diabetes mellitus compared to healthy pregnant controls. J. Diabetes Complications. 1998;12:1–9
  12. Bower JE, Hadi H, Barakat HA. Plasma lipoprotein subpopulation distribution in Caucasian and African–American women with gestational diabetes. Diabetes Care. 2001;24:169–170
  13. Knopp RH, Chapman M, Bergelin R, Wahl PW, Warth MR, Irvine S. Relationships of lipoprotein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care. 1980;3:416–420
  14. Meyers-Seifer CH, Voher BR. Lipid levels in former gestational diabetic mothers. Diabetes Care. 1996;19:1351–1356
  15. De Arcos F, Castelo-Branco C, Casals E, Sanllehy C, Carach V. Normal and gestational diabetic pregnancies: lipids, lipoproteins and apolipoproteins. J. Reprod. Med. 1998;43:144–148
  16. Vitoratos N, Kassanos D, Salamalekis E, Sirisratidis CH, Baimacou E, Creatsas G. Maternal homocysteine levels and plasma lipids in gestational diabetes: is there any relationship?. J. Obstet. Gynaecol. 2002;22:366–369
  17. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J. Clin. Pathol. 1996;49:634–637
  18. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes. 1992;41:1651–1659
  19. Toescu V, Nuttall SL, Martin U, Nightingale P, Kendall MJ, Brydon P, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin. Sci. 2004;106:93–98
  20. Nolan CJ, Riley SF, Sheedy MT. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care. 1995;18:1550–1557
  21. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care. 2003;26:2341–2344
  22. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2002;25:S5–S20
  23. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 1982;144:768–773
  24. R.J. Baker, J.A. Nelder, The generalized linear interactive modeling system, release 3.77, Oxford Numerical Algorithms Group, Oxford, 1985.
  25. Hardin JW, Hilbe J. Generalized Linear Models and Extensions. College Station, TX: Stata Press; 2001;
  26. Hastie TJ, Tibshuani RJ. Generalized Additive Models. London: Chapman & Hall; 1990;
  27. Rothman KJ, Greenland S. Modern Epidemiology. Boston: Little Brown; 1998;
  28. Schaefer EJ, Audelin MC, McNamara JR, Shah PK, Taylor T, Daly JA, et al. Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease. Am. J. Cardiol. 2001;88:1129–1133
  29. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet. Med. 2004;103–113
  30. de Graaf J, Hak-Lemmers H, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 1991;11:298–306
  31. Hurt-Camejo E, Camejo G, Rosengren BE, Lopez F, Ahlstrom C, Fager G, et al. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 1992;12:569–583
  32. Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic β-cell dysfunction. Ann. N. Y. Acad. Sci. 2004;1044:168–176
  33. Kelley DE, Goodpasture B. Skeletal muscle triglyceride. Diabetes Care. 2001;24:933–941
  34. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. U.S.A. 1997;94:4637–4641
  35. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am. J. Hypertens. 2004;574–581

PII: S0168-8227(05)00100-2

doi: 10.1016/j.diabres.2005.03.022

Diabetes Research and Clinical Practice
Volume 70, Issue 2 , Pages 134-142 , November 2005

Article Tools

* Image Usage & Resolution